Prophylaxis of venous thromboembolism in medical patients: too much or too little?

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 10.75

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet (2008) 9.10

Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med (2005) 7.90

A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88

The long-term clinical course of acute deep venous thrombosis. Ann Intern Med (1996) 6.87

Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med (2011) 5.86

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.02

Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ (2010) 2.64

Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med (2011) 2.32

Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost (2006) 2.32

Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology (2006) 1.87

Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ (2011) 1.33

Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health Syst Pharm (2006) 1.12

Venous thromboembolism prophylaxis guideline implementation is improved by nurse directed feedback and audit. Thromb J (2011) 1.01

Prophylaxis rates for venous thromboembolism and gastrointestinal bleeding in general medical patients: too low or too high? BMJ (2012) 0.93

Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE. Am J Med (2010) 0.87

Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond. Circulation (2009) 0.86

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag (2007) 0.86

Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients. Br J Haematol (2008) 0.83

Measures of risk and their relationship to the relative size of a high-risk group: application to medical thromboprophylaxis. Clin Epidemiol (2012) 0.79

Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study. Lancet Haematol (2015) 1.45

Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval. BMJ Open (2015) 0.88

Diagnosis and mortality in prehospital emergency patients transported to hospital: a population-based and registry-based cohort study. BMJ Open (2016) 0.82

Clinical predictors of shockable versus non-shockable rhythms in patients with out-of-hospital cardiac arrest. Resuscitation (2016) 0.78

Hospital use among patients with lung cancer complicated by bone metastases and skeletal- related events: a population-based cohort study in Denmark. Clin Epidemiol (2015) 0.77

The Danish database for acute and emergency hospital contacts. Clin Epidemiol (2016) 0.75

The Danish quality database for prehospital emergency medical services. Clin Epidemiol (2016) 0.75

The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients. Clin Epidemiol (2015) 0.75

Hospital readmission after acute kidney injury--why?*. Crit Care Med (2015) 0.75

Differences in reported sepsis incidence according to study design: a literature review. BMC Med Res Methodol (2016) 0.75

Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012. J Allergy Clin Immunol (2015) 0.75

Impact of co-morbidity on the risk of first-time myocardial infarction, stroke, or death after single-photon emission computed tomography myocardial perfusion imaging. Am J Cardiol (2014) 0.75

Impact of the Charlson Comorbidity Index score on risk prediction by single-photon emission computed tomography myocardial perfusion imaging following myocardial infarction. Clin Epidemiol (2019) 0.75

Performance of SAPS II according to ICU length of stay: A Danish nationwide cohort study. Acta Anaesthesiol Scand (2019) 0.75

Location of cardiac arrest and impact of pre-arrest chronic disease and medication use on survival. Resuscitation (2017) 0.75

Existing Data Sources in Clinical Epidemiology: The Danish COVID-19 Cohort. Clin Epidemiol (2020) 0.75